Oncogenes and signal transduction

Cell

Volumn 64, Issue 2, 1991, Pages 281-302

  Cantley, Lewis C ^a   Auger, Kurt R ^a   Carpenter, Christopher ^a   Duckworth, Brian ^a   Graziani, Andrea ^a   Kapeller, Rosana ^a   Soltoff, Stephen ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE;

HUMAN; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMAL; COMPARATIVE STUDY; HUMAN; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; ONCOGENES; PLATELET-DERIVED GROWTH FACTOR; PROTEIN-TYROSINE KINASE; RECEPTORS, CELL SURFACE; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; SEQUENCE HOMOLOGY, NUCLEIC ACID; SIGNAL TRANSDUCTION; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026069474     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/0092-8674(91)90639-G     Document Type: Review

References (225)

1. Binding of myosin 1 to membrane lipids
2. Requirement for integration of signals from two distinct phosphorylation pathways for activation of MAP kinase
3. Regulation of the association of membrane skeletal protein 4.1 with glycophorin by a polyphosphoinositide
4. Phosphatidylinositol 3-kinase and its novel product, phosphatidylinositol 3-phosphate, are present in Saccharomyces cerevisiae
5. PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells
6. Colony stimulating factor-1 (CSF-1) stimulates temperature dependent phosphorylation and activation of the Raf-1 proto-oncogene product
7. Control of S6 phosphorylation during the mitogenic response
8. lck) that phosphorylates the CD3 complex
9. xe-dependent and -independent pathways
10. Microinjection of the ras oncogene protein into PC12 cells induces morphological differentiation
11. 2 in normal and ras-transformed cells
12. Erythroid membrane-bound protien kinase binds to a membrane component and is regulated by phosphatidylinositol-4,5-bisphosphate
13. Comparison of biological properties and transforming potential of human PDGF-A and PDGF-B chains
14. Multiple sequence elements of a single functional class are required for cyclic AMP responsiveness of the mouse c-fos promoter
15. Molecular themes in carcinogenesis
16. Activated type 1 phosphatidylinositol kinase is associated with the epidermal growth factor (EGF) receptor following EGF stimulation
17. Insulin activates the Raf-1 protein kinase
18. Enhancement of cellular src gene product associated tyrosyl kinase activity following polyoma virus infection and transformation
19. Cloning of a mitogen-inducible gene encoding a κB DNA-binding protein with homology to the rel oncogene and to cell-cycle motifs
20. Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity
21. Growth factor-responsive genes in fibroblasts
22. Cellular proteins that are targets for transformation by DNA tumour viruses
23. Transcriptional induction of the murine c-rel gene with serum and phorbol-12-myristate-13-acetate in fibroblasts
24. Myristic acid, a rare fatty acid, is the lipid attached to the transforming protein of Rous sarcoma virus and its cellular homolog
25. Phosphoinositide kinases
26. Purification and characterization of phosphoinositide 3-kinase from rat liver
27. c-s/c associated with polyomavirus middle tumor antigen
28. c-src mutated in the carboxy-terminal regulatory domain
29. c-src
30. The mammalian G protein rhoC is ADP-ribosylated by Clostridium botulinum exoenzyme C3 and affects actin microfilaments in Vero cells
31. NPXY, a sequence often found in cytoplasmic tails, is required for coated pit-mediated internalization of the low density lipoprotein receptor
32. c-tyn is capable of complex formation with the middle-T antigen of polymavirus
33. c-src is a regulatory domain and is involved in complex formation with the middle-T antigen of polyomavirus
34. c-src by the middle T antigen of polyomavirus
35. Human colony stimulating factor-1 receptor activates the c-Raf-1 proto-oncogene kinase
36. Interaction between the EGF receptor and phosphatidylinositol kinases
37. Characterization of pp85, a target of oncogenes and growth factor receptors
38. Tyrosine phosphorylation is a signal for the trafficking of pp85, an 85-kDa phosphorylated polypeptide associated with phosphatidyinositol kinase activity
39. The amino terminus of polyomavirus middle T antigen is required for transformation
40. c-src: implications for regulation
41. c-myc gene expression is stimulated by agents that activate protein kinase C and does not account for the mitogenic effect of PDGF
42. Role of phosphatidylinositol kinase in PDGF receptor signal transduction
43. c-src kinase by middle T antigen binding or by dephosphorylation
44. c-src: a possible phosphatidylinositol kinase
45. Polyoma virus transforming protein associates with the product of the c-src cellular gene
46. src myristylation and membrane association and for cell transformation
47. Growth factors in development, transformation, and tumorigenesis
48. Increased tyrosine phosphorylation in res-transformed fibroblasts occurs prior to manifestation of the transformed phenotype
49. Fos and Jun: the AP-1 connection
50. lck is hyperphosphorylated on serine and tyrosine residues within minutes after activation T cell receptor or CD2
51. EGF receptor and erbB-2 tyrosine kinase domains confer cell specificity for mitogenic signaling
52. ras upon T-cell activation
53. Human cdc2 protein kinase is a major cell-cycle regulated tyrosine kinase substrate
54. Homology of a yeast actin-binding protein to signal transduction proteins and myosin-I
55. A completely transformation-defective point mutant of polyomavirus middle t antigen which retains full associated phosphatidylinositol kinase activity
56. Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases
57. A 42-kD tyrosine kinase substrate linked to chromaffin cell secretion exhibits an associated MAP kinase activity and is highly related to a 42-kD mitogen-stimulated protein in fibroblasts
58. Phosphatidyl-inositol kinase or an associated protein is a substrate for the insulin receptor tyrosine kinase
59. A phosphatidylinositol 3-kinase binds to platelet derived growth factor receptor sequence containing phosphotyrosine
60. Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP
61. Platelet tyrosine-specific protein phosphorylation is regulated by thrombin
62. Thrombin stimulates the activities of multiple previously unidentified protein kinases in platelets
63. Multiple sequence elements in the c-fos promoter mediate induction by cAMP
64. Ras-transformed cells: altered levels of phosphatidylinositol-4,5-bisphosphate and catabolites
65. src protein
66. Phosphatidylinositol kinase type I activity associates with various oncogene products
67. Activation of the c-fos serum-response element by the activated c-Ha-ras protein in a manner independent of protein kinase C and cAMP-dependent protein kinase
68. ras-induced c-fos expression and proliferation in living rat fibroblasts involves C-kinase activation and the serum response element pathway
69. Activation in vitro of NF κB by phosphorylation of its inhibitor IκB
70. Cloning of the p50 DNA binding subunit of NF-κB: homology to rel and dorsal
71. The c-fos serum response element to protein kinase C-dependent and -independent signals but not cyclic AMP
72. Thrombin treatment induces rapid changes in tyrosine phosphorylation in platelets
73. 2 and inhibits its hydrolysis by phospholipase C
74. c-src and increases its protein-tyrosine kinase activity
75. + protein kinase regulates entry into mitosis
76. cDNA cloning and sequencing of the protein-tyrosine kinase substrate, ezrin, reveals homology to band 4.1
77. Co-capping of ras proteins with surface immunoglobins in B lymphocytes
78. Evidence that the Rous sarcoma virus transforming gene product is associated with glycerol kinase activity
79. fyn in human platelets
80. The cellular functions of small GTP-binding proteins
81. v-src has competence activity but does not activate phosphatidylinositol turnover or protein kinase C in Balb/c 3T3 cells
82. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains
83. Signal transduction by the receptors for platelet-derived growth factor
84. PDGF-induced activation of phospholipase C is not required for induction of DNA synthesis
85. c-src
86. Cooperation between oncogenes
87. Protein-tyrosine kinases
88. Targets for signal-transducing protein kinases
89. N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl
90. Transactivation of c-fos and β-actin genes by raf as a step in early response to transmembrane signals
91. Gelsolin-polyphosphoinositide interaction
92. Fibroblasts transformed with v-src show enhanced formation of an inositol tetrakisphosphate
93. Activation of the serum response element and 12-O-tetradecanoylphorbol-13-acetate response element by the activated c-ref-1 protein in a manner independent of protein kinase C
94. src prevents both myristoylation and morphological transformation
95. Phosphatidylinositol metabolism and polyoma-mediated transformation
96. Common elements in growth factor stimulation and oncogenic transformation 85 kd phosphoprotein and phosphatidylinositol kinase activity
97. Mechanisms of transformation by polyoma virus middle T antigen
98. PDGF β-receptor stimulates tyrosine phosphorylation of GAP and association of GAP with a signaling complex
99. Protein kinase C mediates platelet-derived growth factor-induced tyrosine phosphorylation of p42
100. Autophosphorylation of the PDGF receptor in the kinase insert region regulates interactions with cell proteins
101. Binding of GAP to activated PDGF receptors
102. The DNA binding subunit of NF-κB is identical to factor KBF1 and homologous to the rel oncogene product
103. c-src transforming ability to mutation of its primary sites of tyrosine phosphorylation
104. The common src homology region 2 domain of cytoplasmic signalling proteins is a positive effector of v-fps tyrosine kinase function
105. c-yes with polyomavirus middle T-antigen mutants correlates with transforming ability
106. Insulin activates the kinase activity of the Raf-1 proto-oncogene by increasing its serine phosphorylation
107. fyn (a src-like protein tyrosine kinase) in normal and polyoma virus transformed cells
108. Association between the PDGF receptor and members of the src family of tyrosine kinases
109. Involvement of functional protein kinase C in the mitogenic response to the H-ras oncogene product
110. Novel source of 1,2-diacylglycerol elevated in cells transformed by Ha-ras oncogene
111. s and stimulate adenylyl cyclase in human pituitary tumours
112. Phospholipase C-mediated hydrolysis of phosphatidylcholine is an important step in PDGF-stimulated DNA synthesis
113. Specific interaction between phosphatidylinositol 4,5-bisphosphate and profilactin
114. Purification and complementary DNA cloning of a receptor for basic fibroblast growth factor
115. NF-κB: a pleiotropic mediator of inducible and tissue-specific gene control
116. Driving the cell cycle: M phase kinase, its partners, and substrates
117. Phosphatidylinositol 3-phosphate is present in normal and transformed fibroblasts and is resistant to hydrolysis by bovine brain phospholipase C II
118. Kinetic evidence of a rapid activation of phosphatidylcholine hydrolysis by Ki-ras oncogene. Possible involvement in late steps of the mitogenic cascade
119. lck whose phosphorylation is induced by tetradecanoyl phorbol acetate
120. Two G protein oncogenes in human endocrine tumors
121. Oncogenes and cellular signal transduction
122. Transforming protein of avian sarcoma virus UR2 is associated with phosphatidylinositol kinase activity: possible role in tumorigenesis
123. Xenopus oocytes and the biochemistry of cell division
124. EGF induces tyrosine phosphorylation of phospholipase C-II: a potential mechanism for EGF receptor signaling
125. Tumor suppressor genes
126. g8g-crk to a broad range of phosphotyrosine-containing proteins
127. Association of the v-crk oncogene product with phosphotyrosine-containing proteins and protein kinase activity
128. A novel viral oncogene with structural similarity to phospholipase C
129. High-affinity binding of the noncatalytic SH2 segment of the abl tyrosine kinase to tyrosine-phosphorylated cellular proteins
130. v-src
131. ras GTPase activating protein: signal transmitter and signal terminator
132. Multiple synergistic signal transduction pathways regulate c-fos expression in Swiss 3T3 cells: the role of cyclic AMP
133. Regulation of S6 kinase activity in Madin-Darby canine kidney renal epithelial cells
134. Phospholipase C-γ is a substrate for the PDGF and EGF receptor protein-tyrosine kinase in vivo and in vitro
135. PDGF induction of tyrosine phosphorylation of GTPase activating protein
136. cdc2-associated protein kinase
137. Signal transduction from membrane to cytoplasm: growth factors and membrane-bound oncogene products increase Raf-1 phosphorulation and associated protein kinase activity
138. Direct activation of the serine/threonine kinase activity of Raf-1 through tyrosine phosphorylation by the PDGF β-receptor
139. Platelet-derived growth factor (PDGF)-dependent association of phospholipase C-γ with the PDGF receptor signaling complex
140. lck by the leukocyte common antigen (CD45)
141. Guanine nucleotides induce tyrosine phosphorylation and activation of the respiratory burst in neutrophils
142. Deletions within the amino-terminal half of the c-src gene product that alter the functional activity of the protein
143. Increase of the catalytic activity of phospholipase C-γ1 by tyrosine phosphorylation
144. c-src by point mutations in the SH2 domain
145. c-src function
146. lck
147. Polyoma small and middle T antigens and SV40 small t antigen form stable complexes with protein phosphatase 2A
148. rho induces rapid changes in cell morphology
149. v-src of Prague Rous sarcoma virus
150. Epidermal growth factor-dependent phosphorylation of lipocortin
151. Epidermal growth factor increases the labeling of phosphatidylinositol 3,4-bisphosphate in MA-10 Leydig tumor cells
152. c-src
153. c-src and its interaction with polyomavirus middle T antigen in insect cells
154. ras
155. Biochemical characterization of baculovirus-expressed rap1A/Krev-1 and its regulation by GTPase-activating proteins
156. Lymphocyte activation
157. Interactions of phosphatidylinositol kinase, GTPase-activating protein (GAP), and GAP-associated proteins with the colony-stimulating factor 1 receptor
158. c-src level in human platelet dense bodies
159. v-src
160. Activation of the oncogenic potential of the avian cellular src protein by specific structural alteration of the carboxy terminus
161. src with two tyrosine-phosphorylated cellular proteins
162. Microinjection of the catalytic subunit of cAMP-dependent protein kinase induces expression of the c-fos gene
163. Regulation of c-raf serine kinase by tyrosine kinases
164. Identity of inositol 1,2-cyclic phosphate 2-phosphohydrolase with lipocortin III
165. A point mutation at tyrosine-809 in the human colony-stimulating factor 1 receptor impairs mitogenesis without abrogating tyrosine kinase activity, association with phosphatidylinositol 3-kinase, or induction of c-fos and junB genes
166. xe proto-oncogene product
167. lck complex in human T-cell activation
168. Activation of phosphatidylinositol 3-kinase by insulin
169. The c-mos proto-oncogene product is a cytostatic factor responsible for meiotic arrest in vertebrate eggs
170. Association of the fyn protein-tyrosine kinase with the T-cell antigen receptor
171. The cDNA sequence for the protein-tyrosine kinase substrate p36 (calpactin I heavy chain) reveals a multidomain protein with internal repeats
172. ras-GTP complex in Swiss mouse 3T3 cells
173. c-src on tyrosine 527
174. Polyphosphoinositides produced by phosphatidylinositol 3-kinase are poor substrates for phospholipase C from rat liver and bovine brain
175. Production of novel polyphosphoinositides in vivo is linked to transformation by polyoma virus middle T antigen
176. Deletion of the kinase insert sequence of the platelet-derived growth factor β-receptor affects receptor kinase activity and signal transduction
177. The lck tyrosine protein kinase interacts with the cytoplasmic tail of the CD4 glycoprotein through its unique amino-terminal domain
178. lck tyrosine protein kinase
179. c-src at the sites phosphorylated during fibroblast mitosis
180. Structural features of the colony-stimulating factor 1 receptor that affect its association with phosphatidylinositol 3-kinase
181. Requirement for c-ras proteins during viral oncogene transformation
182. S-phase induction and transformation of quiescent NIH 3T3 cells by microinjection of phospholipase C
183. Induction of transformation and DNA synthesis after microinjection of raf proteins
184. Protein kinases: regulation by autoinhibitory domains
185. Microinjection of transforming ras protein induces c-fos expression
186. Sequence similarity of phospholipase C with the non-catalytic region of src
187. i into myo-inositol 1,3,4,6-tetrakisphosphate, myo-inositol 1,3,4,5-tetrakisphophate, myo-inositol 3,4,5,6-tetrakisphosphate and myo-inositol 1,3,4,5,6,-pentakisphosphate in intact avian erythrocytes
188. Stepwise phosphorylation of myo-inositol leading to myo-inositol hexakisphosphate in Dictyostelium
189. Identification of c-fos sequences involved in induction by insulin and phorbol esters
190. Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II
191. Evidence that the Rous sarcoma virus transforming gene product phosphorylates phosphatidylinositol and diacylglycerol
192. Cloning and sequence of multiple forms of phospholipase C
193. Inositol phospholipid-specific phospholipase C complete cDNA and protein sequences and sequence homology to tyrosine kinase-related oncogene products
194. EGF induces biphasic S6 kinase activation: late phase is protein kinase C-dependent and contributes to mitogenicity
195. c-src: a switch for binding of phosphatidylinositol 3-kinase and optimal tumorigenesis
196. lck with cytoplasmic domains of CD4 and CD8 is mediated by cysteine motifs
197. Signal transduction by receptors with tyrosine kinase activity
198. Phosphatidylinositol metabolism in cells transformed by polyomavirus middle t antigen
199. The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization
200. The colony stimulating factor-1 receptor associates with and activates phosphatidylinositol-3 kinase
201. Activation of PI 3-kinase in cells expressing abl oncogene variants
202. Structural nature of the interaction between T lymphocyte surface molecule CD4 and the intracellular protein tyrosine kinase lck
203. lck
204. v-src restricts transformation in a host-dependent manner
205. neu protein and EGF receptor modulates EGF receptor function
206. Antiphosphotyrosine recovery of phospholipase C activity after EGF treatment of A-431 cells
207. Platelet-derived growth factor induces rapid and sustained tyrosine phosphorylation of phospholipase C-γ in quiescent BALB/c 3T3 cells
208. v-src inactivate transformation and modulate membrane stability
209. sis of simian sarcoma virus
210. The retinoblastoma gene and cell growth control
211. v-src do not phosphorylate cellular proteins of 120–150 kDA
212. Phosphoinositide metabolism and the control of cell proliferation
213. Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation
214. Evidence for two distinct phosphatidylinositol kinases in fibroblasts: implications for cellular regulation
215. Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate
216. GAPs in understanding Ras
217. Elevated levels of diacylglycerol and decreased phorbol ester sensitivity in ras-transformed fibroblasts
218. ras
219. The neurofibromatosis type 1 gene encodes a protein related to GAP
220. A novel pathway for the formation of phosphatidylinositol(3,4)bisphosphate: phosphorylation of phosphatidylinositol(3) monophosphate by phosphatidylinositol(3)monophosphate 4-kinase
221. Growth factor receptor tyrosine kinases
222. + channels
223. Cellular ras activity and phospholipid metabolism
224. Suppression of c-ras transformation by GTPase-activating protein
225. Identification of small clusters of divergent amino acids that mediate the opposing effects of ras and Krev-1